Liposoluble vitamins in patients receiving longterm treatment with octreotide.

Liposoluble vitamins in patients receiving long-term octreotide treatment.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24514

Enrollment

Registered

2009-03-17

Start date

2009-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vetoplosbare vitamine deficientie, carcinoid tumor, acromegalie Liposoluble vitamin deficiency, carcinoid tumour, acromegaly

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients are eligible when they have used octreotide for at least 18 months. Patients must be 18 years or older and must be willing to give written informed consent.

Exclusion criteria

Exclusion criteria: No informed consent, age less then 18 years.

Design outcomes

Primary

Measure	Time frame
1. Liposoluble vitamins; 2. Relevant lipid components; 3. Relevant biochemical investigations to measure effects of possible vitamin deficiency, including calcium levels, PTH and coagulation.	—

Contacts

Public ContactH.B. Fiebrich

Universitair Medisch Centrum Groningen Postbus 30.001

h.b.fiebrich@int.umcg.nl+31 (0)50-36161616

Outcome results